|
EP3753563A1
|
|
Anti-herpesvirus guanosine analogue for the inhibition of basal autophagy
|
|
EP3785719A1
|
|
New use of cyclic dinucleotides
|
|
AU2019297409A1
|
|
PqsR inverse agonists
|
|
WO2019122400A1
|
|
Gene cluster for the biosynthetic production of tetracycline compounds in a heterologous host
|
|
CN110997627A
|
|
Novel cystobacter amide derivatives
|
|
AU2018315154A1
|
|
New targeted cytotoxic ratjadone derivatives and conjugates thereof
|
|
WO2019016298A1
|
|
Herpes reporter virus for phase-specific interrogation of the viral replication cycle
|
|
EP3630094A1
|
|
Carolacton and derivatives thereof for use in the treatment of cell proliferation disorders
|
|
WO2018197621A1
|
|
Salmonella and immunogenic composition containing the same as well as its use
|
|
EP3543698A1
|
|
Method for determining vaccine efficacy in an individual and means therefore
|
|
EP3498714A1
|
|
Novel sorangicin antibiotic
|
|
EP3421050A1
|
|
Aminoglycoside derivatives and nano-assemblies thereof, including those with quorum sensing inhibitory function
|
|
EP3348651A1
|
|
Rapid antimicrobial susceptibility testing and phylogenetic identification
|
|
EP3166934A1
|
|
Novel macrolide antibiotics
|
|
EP3129385A1
|
|
Neosoraphens and their use in the treatment or prevention of a viral infection or of a th17-associated inflammatory and/or autoimmune disease
|
|
EP3019615A2
|
|
Cystobactamides
|
|
EP2994535A1
|
|
Production of myxopyronin and of its derivatives
|
|
US2017022165A1
|
|
PQSR modulators
|
|
EP3111937A1
|
|
Medicament for treatment of liver cancer
|
|
AU2003252540A1
|
|
Novel macrocycles for the treatment of cancer
|
